JANE POMRANKY: Open Payments
NPI 1093170565 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 60 payments from 14 companies in 2025. Trend: 2023 $988 · 2024 $853 · 2025 $1,183
Food & beverage: $1,183
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 35 | $570 |
| AstraZeneca Pharmaceuticals LP | 7 | $183 |
| Kestra Medical Technology Services, Inc. | 1 | $90 |
| GENZYME CORPORATION | 4 | $65 |
| Insmed, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Fisher & Paykel Healthcare Inc | 1 | $26 |
Products named: NUCALA, TRELEGY ELLIPTA, AIRSUPRA, Assure WCD, DUPIXENT, Arikayce, GLASSIA, TEZSPIRE.
Industry payments across IL — which companies pay providers there.
